Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hatch Bill Seeks To Restore Supplements, OTCs To Health Accounts

This article was originally published in The Tan Sheet

Executive Summary

A bill introduced by Sen. Orrin Hatch would allow consumers to again purchase supplements and OTC drugs with pre-tax health savings accounts.

You may also be interested in...



ACA Amendments More Likely Than Repeal, Former Senators Predict

Republican efforts to repeal the Affordable Care Act will fail, former Sen. Dorgan maintains, saying “this law will remain a part of our future for some long while.” Former Sen. Bennett expects amendments to focus on “the relentlessly increasing cost of health care.”

ACA Amendments More Likely Than Repeal, Former Senators Predict

Republican efforts to repeal the Affordable Care Act will fail, former Sen. Dorgan maintains, saying “this law will remain a part of our future for some long while.” Former Sen. Bennett expects amendments to focus on “the relentlessly increasing cost of health care.”

Hearing Targets Health Account OTC Issue As Reform Law Proxy

Republicans on the Subcommittee on Oversight oppose the provision in health care reform requiring consumers to have a prescription to purchase OTCs with pre-tax savings account funds. Democrats argue the revenue is needed to pay for health care reform and lower costs for everyone.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel